We are live on
!
Find out more
Sensei Biotherapeutics
SNSE
SNSE
30 hedge funds and large institutions have $68M invested in Sensei Biotherapeutics in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
167.15% more ownership
Funds ownership: 3.83% → 170.97% (+167%)
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$14.4M | |
| 2 | +$6.12M | |
| 3 | +$2.93M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$2.67M |
| 5 |
SC
Stempoint Capital
New York
|
+$2.65M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $143K |
|
|||
|
TRCT
27
Tower Research Capital (TRC)
New York
| $47.2K |
|
|||
28
JP Morgan Chase
New York
| $804 |
|
|||
29
BNP Paribas Financial Markets
Paris,
France
| $284 |
|
|||
|
SS
30
SBI Securities
Tokyo,
Japan
| $126 |
|
|||
31
Citigroup
New York
| – |
|
|||
|
BP
32
BNP Paribas
Paris,
France
| – |
|